NO171211C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksanerInfo
- Publication number
- NO171211C NO171211C NO881768A NO881768A NO171211C NO 171211 C NO171211 C NO 171211C NO 881768 A NO881768 A NO 881768A NO 881768 A NO881768 A NO 881768A NO 171211 C NO171211 C NO 171211C
- Authority
- NO
- Norway
- Prior art keywords
- dioxanes
- preparation
- therapeutic active
- analogy procedure
- analogy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878709794A GB8709794D0 (en) | 1987-04-24 | 1987-04-24 | Heterocyclic acids |
Publications (4)
Publication Number | Publication Date |
---|---|
NO881768D0 NO881768D0 (no) | 1988-04-22 |
NO881768L NO881768L (no) | 1988-10-25 |
NO171211B NO171211B (no) | 1992-11-02 |
NO171211C true NO171211C (no) | 1993-02-10 |
Family
ID=10616328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO881768A NO171211C (no) | 1987-04-24 | 1988-04-22 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner |
Country Status (21)
Country | Link |
---|---|
US (1) | US4921866A (pt) |
EP (1) | EP0288279B1 (pt) |
JP (1) | JP2620298B2 (pt) |
KR (1) | KR880012583A (pt) |
CN (1) | CN1015893B (pt) |
AU (1) | AU609466B2 (pt) |
CA (1) | CA1312084C (pt) |
DD (1) | DD281385A5 (pt) |
DE (1) | DE3874394T2 (pt) |
DK (1) | DK217388A (pt) |
FI (1) | FI881829A (pt) |
GB (2) | GB8709794D0 (pt) |
HU (1) | HU204522B (pt) |
IL (1) | IL86066A (pt) |
MY (1) | MY103368A (pt) |
NO (1) | NO171211C (pt) |
NZ (1) | NZ224345A (pt) |
PL (1) | PL272024A1 (pt) |
PT (1) | PT87301B (pt) |
ZA (1) | ZA882528B (pt) |
ZW (1) | ZW3888A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8901201D0 (en) * | 1988-02-16 | 1989-03-15 | Ici Plc | Pyridine derivatives |
US5248780A (en) * | 1988-02-16 | 1993-09-28 | Imperial Chemical Industries, Plc | Pyridyl substituted alkenoic acid derivatives |
IE81170B1 (en) * | 1988-10-21 | 2000-05-31 | Zeneca Ltd | Pyridine derivatives |
DE4018260A1 (de) * | 1990-06-07 | 1991-12-12 | Basf Ag | Derivate des (beta)-picolins und diese enthaltende pflanzenschutzmittel |
GB9021571D0 (en) * | 1990-10-04 | 1990-11-21 | Ici Plc | Heterocyclic acids |
CA2676435C (en) * | 2007-01-18 | 2015-03-24 | Evolva Sa | Substituted 1,3-dioxanes useful as ppar modulators |
DE102007010077B4 (de) | 2007-02-28 | 2010-04-08 | RUHR-UNIVERSITäT BOCHUM | [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren |
EP4190308A1 (de) | 2021-12-06 | 2023-06-07 | Marome GmbH | Schlafduft sowie herstellung und verwendung von diesem |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8310407D0 (en) * | 1982-05-12 | 1983-05-25 | Ici Plc | 1 3 - dioxan -5- ylalkenoic acids |
GB8330120D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Chemical process |
GB8511896D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Alkenes |
DE3685775T2 (de) * | 1985-05-10 | 1993-01-21 | Ici Plc | Alkenderivate. |
GB8511890D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Benzene derivatives |
GB8901201D0 (en) * | 1988-02-16 | 1989-03-15 | Ici Plc | Pyridine derivatives |
-
1987
- 1987-04-24 GB GB878709794A patent/GB8709794D0/en active Pending
-
1988
- 1988-04-08 GB GB888808338A patent/GB8808338D0/en active Pending
- 1988-04-11 ZA ZA882528A patent/ZA882528B/xx unknown
- 1988-04-11 ZW ZW38/88A patent/ZW3888A1/xx unknown
- 1988-04-14 IL IL86066A patent/IL86066A/xx not_active IP Right Cessation
- 1988-04-19 FI FI881829A patent/FI881829A/fi not_active Application Discontinuation
- 1988-04-19 AU AU14761/88A patent/AU609466B2/en not_active Ceased
- 1988-04-20 CA CA000564577A patent/CA1312084C/en not_active Expired - Fee Related
- 1988-04-21 DK DK217388A patent/DK217388A/da unknown
- 1988-04-21 EP EP88303585A patent/EP0288279B1/en not_active Expired - Lifetime
- 1988-04-21 DE DE8888303585T patent/DE3874394T2/de not_active Expired - Fee Related
- 1988-04-22 PT PT87301A patent/PT87301B/pt not_active IP Right Cessation
- 1988-04-22 DD DD88315013A patent/DD281385A5/de not_active IP Right Cessation
- 1988-04-22 HU HU882042A patent/HU204522B/hu not_active IP Right Cessation
- 1988-04-22 NZ NZ224345A patent/NZ224345A/en unknown
- 1988-04-22 NO NO881768A patent/NO171211C/no not_active IP Right Cessation
- 1988-04-22 PL PL27202488A patent/PL272024A1/xx unknown
- 1988-04-23 CN CN88102356A patent/CN1015893B/zh not_active Expired
- 1988-04-23 KR KR1019880004716A patent/KR880012583A/ko not_active Application Discontinuation
- 1988-04-23 MY MYPI88000425A patent/MY103368A/en unknown
- 1988-04-25 US US07/185,873 patent/US4921866A/en not_active Expired - Fee Related
- 1988-04-25 JP JP63100439A patent/JP2620298B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NO881768D0 (no) | 1988-04-22 |
DE3874394D1 (en) | 1992-10-15 |
EP0288279A3 (en) | 1990-05-30 |
AU609466B2 (en) | 1991-05-02 |
GB8808338D0 (en) | 1988-05-11 |
NO171211B (no) | 1992-11-02 |
EP0288279A2 (en) | 1988-10-26 |
DD281385A5 (de) | 1990-08-08 |
CA1312084C (en) | 1992-12-29 |
CN88102356A (zh) | 1988-12-28 |
JPS63280082A (ja) | 1988-11-17 |
FI881829A (fi) | 1988-10-25 |
IL86066A0 (en) | 1988-09-30 |
EP0288279B1 (en) | 1992-09-09 |
MY103368A (en) | 1993-06-30 |
HU204522B (en) | 1992-01-28 |
AU1476188A (en) | 1988-10-27 |
PT87301A (pt) | 1988-05-01 |
DK217388A (da) | 1988-10-25 |
US4921866A (en) | 1990-05-01 |
PT87301B (pt) | 1992-08-31 |
NO881768L (no) | 1988-10-25 |
ZW3888A1 (en) | 1989-11-22 |
ZA882528B (en) | 1988-10-24 |
JP2620298B2 (ja) | 1997-06-11 |
DE3874394T2 (de) | 1993-02-25 |
HUT50157A (en) | 1989-12-28 |
GB8709794D0 (en) | 1987-05-28 |
DK217388D0 (da) | 1988-04-21 |
KR880012583A (ko) | 1988-11-28 |
PL272024A1 (en) | 1989-01-23 |
FI881829A0 (fi) | 1988-04-19 |
NZ224345A (en) | 1991-07-26 |
IL86066A (en) | 1992-11-15 |
CN1015893B (zh) | 1992-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO171787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser | |
NO871267D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
NO871588L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider. | |
NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
NO883122D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
NO883485D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
NO171909C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
NO890155D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
NO880667L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
NO173061C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner | |
NO172802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner | |
NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
NO168040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3'-demetoksyepipodofyllotoksin-glukosidderivater. | |
NO162072C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater. | |
NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. | |
NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
NO883959L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. | |
NO882282L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
NO166715C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN OCTOBER 2001 |